argenx SE

Status: Publicly traded

Direct answer

argenx SE is publicly traded on NASDAQ under the ticker ARGX.

argenx SE, a biotechnology company established in Amsterdam, the Netherlands, in 2008, is dedicated to developing innovative therapies primarily for autoimmune diseases. The company's operations span across key global markets, including the United States, Japan, Europe, the Middle East, Africa, and China. Its leading investigational therapy is efgartigimod, which is being developed to address a broad range of...

Can you invest in argenx SE?

Yes. argenx SE trades publicly on NASDAQ as ARGX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for argenx SE

Detailed equity research is provided by MarketSnap.